Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2014
10/30/2014US20140323480 Imidazopyridine Derivatives As PI3 Kinase
10/30/2014US20140323479 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
10/30/2014US20140323478 Serine/threonine kinase inhibitors
10/30/2014US20140323477 Serine/threonine kinase inhibitors
10/30/2014US20140323475 Ep1 receptor ligands
10/30/2014US20140323470 Kinase inhibitors
10/30/2014US20140323468 Aldosterone synthase inhibitors
10/30/2014US20140323464 Kinase inhibitors
10/30/2014US20140323463 Pyrazinecarboxamide compound
10/30/2014US20140323458 Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
10/30/2014US20140323447 Heteroaromatic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
10/30/2014US20140323420 Reducing transmission of sexually transmitted infections
10/30/2014US20140323418 Selective kinase inhibitors
10/30/2014US20140322636 Electrophotographic photosensitive member, process cartridge, electrophotographic apparatus, and imide compound
10/30/2014US20140322195 Factor IXA Inhibitors
10/28/2014US8872422 Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
10/28/2014US8871933 Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
10/28/2014US8871932 Process for the preparation of tadalafil
10/28/2014US8871929 Fused-imidazoyl compounds useful as antimicrobial agents
10/28/2014US8871928 Tricyclic compounds, preparation methods, and their uses
10/28/2014US8871798 Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors
10/28/2014US8871786 Azaindazole amide compounds as CCR1 receptor antagonists
10/28/2014US8871784 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
10/28/2014US8871782 Alkoxy substituted imidazoquinolines
10/28/2014US8871774 Inhibitors of influenza viruses replication
10/28/2014US8871771 Salts of prodrugs of piperazine and substituted piperidine antiviral agents
10/28/2014US8871770 Carboxamide compounds and methods for using the same
10/28/2014US8871763 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
10/28/2014US8871760 [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
10/28/2014US8871754 Compounds and compositions for the treatment of parasitic diseases
10/28/2014US8871210 Chemokine receptor antagonists and use thereof
10/23/2014US20140316133 Beta-lactamase inhibitors
10/23/2014US20140315945 Substituted Benzene Compounds
10/23/2014US20140315944 Substituted naphthyridine and quinoline compounds as mao inhibitors
10/23/2014US20140315928 Substituted amide compounds
10/23/2014US20140315926 Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
10/23/2014US20140315923 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof
10/23/2014US20140315909 3,5-(Un)substituted-1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H- pyrrolo[2,3-b]pyrazine dual ITK and JAK3 Kinase Inhibitors
10/23/2014US20140315905 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
10/23/2014US20140315902 Bicyclic heterocycles as fgfr inhibitors
10/23/2014US20140315901 Arylpyrrolopyridine derived compounds as LRRK2 inhibitors
10/23/2014US20140315889 Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof
10/23/2014US20140315888 Novel heterocyclic derivatives and their uses
10/23/2014US20140315884 Ampk-activating heterocyclic compounds and methods for using the same
10/23/2014US20140315880 3,6-diazabicyclo[3.1.1]heptaines as neuronal nicotinic acetycholine receptor ligands
10/23/2014US20140315876 Beta-lactamase inhibitors
10/23/2014US20140315857 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
10/23/2014US20140315856 Aminopyrazole derivative
10/23/2014US20140315794 Antiparisitic dihydroazole compounds and compositions comprising same
10/21/2014US8866134 Light-emitting device and photovoltaic cell, and method for manufacturing the same
10/21/2014US8865911 Compounds and their use as BACE inhibitors
10/21/2014US8865907 Method of producing pyrone and pyridone derivatives
10/21/2014US8865758 Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
10/21/2014US8865736 Antibacterial agents
10/21/2014US8865735 Solid forms of a pharmaceutically active substance
10/21/2014US8865731 Inhibitor of analgesic tolerance
10/21/2014US8865727 Method for treating pain syndrome and other disorders
10/21/2014US8865713 Benzoimidazoles as prolyl hydroxylase inhibitors
10/21/2014US8865712 Heterocyclic derivatives and their use in the treatment of neurological disorders
10/21/2014US8865711 Phenylimidazole derivatives as PDE10A enzyme inhibitors
10/21/2014US8865705 Benzimidazole respiratory syncytial virus inhibitors
10/21/2014US8865704 Wnt pathway antagonists
10/21/2014US8865702 B1-antagonists
10/21/2014US8865701 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease
10/21/2014US8865699 Amino triazoles as PI3K inhibitors
10/21/2014US8865698 Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds
10/16/2014US20140309425 Method for synthesizing 1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine-3-formamidine hydrochloride
10/16/2014US20140309424 Direct synthesis of 18f-fluoromethoxy compounds for pet imaging and the provision of new precursors for direct radiosynthesis of protected derivatives of o-([18f] fluoromethyl) tyrosine
10/16/2014US20140309421 Processes and intermediates for producing azaindoles
10/16/2014US20140309254 Pyrrolopyridine derivatives and their use as crth2 antagonists
10/16/2014US20140309249 Inhibitors of c-jun-n-terminal kinase (jnk)
10/16/2014US20140309213 Inhibitors of the renal outer medullary potassium channel
10/16/2014US20140309211 Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
10/16/2014US20140309210 Indazole compounds, compositions and methods of use thereof
10/16/2014US20140309209 Pyrazine Kinase Inhibitors
10/16/2014US20140309191 Salts, prodrugs and polymorphs of fab i inhibitors
10/16/2014US20140309185 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides
10/16/2014US20140308282 Pharmaceutical compounds
10/14/2014US8859777 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators
10/14/2014US8859775 Pyrazolopyridinone derivatives as LPA receptor antagonists
10/14/2014US8859774 Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
10/14/2014US8859773 N1/N2-lactam acetyl-CoA carboxylase inhibitors
10/14/2014US8859772 Selective bromination of perylene diimides and derivatives thereof under mild conditions
10/14/2014US8859764 Methods and compositions for preparing noribogaine from voacangine
10/14/2014US8859609 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
10/14/2014US8859583 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
10/14/2014US8859582 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
10/14/2014US8859581 Azaheterocyclic compounds as kinase inhibitors
10/14/2014US8859580 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
10/14/2014US8859569 Substituted annellated pyrimidines and use thereof
10/14/2014US8859567 Hydrate of 1-{(2S)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di-hydropyrido[3,4-D]pyrimidin-7(6H)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate
10/14/2014US8859563 Bicyclic pyrimidinones and uses thereof
10/14/2014US8859561 Pyrido[4,3-b]indoles and methods of use
10/14/2014US8859545 Tetrahydronaphthyridine and tetrahydropyrido[4,3-D]pyrimidine compounds and compositions thereof useful for the treatment of inflammatory and respiratory diseases
10/14/2014US8859544 Indolizine derivatives, process for the preparation thereof and therapeutic use thereof
10/14/2014US8859541 6-alkynylpyridines
10/14/2014US8859529 Compounds for the treatment of inflammatory disorders
10/14/2014US8859111 Materials for organic electroluminescent devices
10/09/2014WO2014165143A1 Dihydro-pyrrolopyridinone bromodomain inhibitors
10/09/2014WO2014165127A1 Pyrrole amide inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 646